Sign in
Not yet taking people in United StatesNo phase

Quit-Smoking Study for Native Hawaiians

Key facts

Who runs it
University of Hawaii
Where
Honolulu, United StatesSee the site
Trial code
Status
Not yet recruiting
People taking part
75 people, planned
Started
1 Apr 2026
Expected to end
1 Apr 2028
Type of study
Interventional, 3 groups
Treatments tested
  • Nicotine Polacrilex Gum (2 mg)
  • Cognitive Behavioral Group Therapy (CBGT)
Record updated
31 March 2026

Who can take part

Age
18 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (18)Hide the full registry criteria

Who can take part

  • Self-identifies as full or part Native Hawaiian
  • Between the ages of 18 and 80 years, inclusive, at eligibility screening
  • Currently smoking ≥5 cigarettes per day (self-report) at eligibility screening
  • Has smoked more than 100 cigarettes in his/her lifetime (self-report)
  • Affiliated with one of three (3) designated public housing complexes at which the intervention will be delivered: Kalihi Valley Homes, Kuhio Park Terrace, Mayor Wright Housing
  • Willing to make a smoking cessation attempt the day after the first study visit (i.e., date of consent)
  • Willing to engage in use of nicotine replacement therapy gum (NRT gum) and/or smoking cessation-focused cognitive-behavioral group therapy (CBGT)
  • Participant must agree to not use any form of pharmacotherapy (i.e., prescription medication or any form of nicotine replacement therapy) to try to quit smoking during the 12-week study period, except as specifically assigned to his or her study condition and distributed by the research team
  • Participant must agree to not use other tobacco or nicotine products (e.g., cigars, little cigars, electronic cigarettes, nicotine pouches) during the 12-week study period
  • Participant must agree to not smoke or vape cannabis (i.e., marijuana) during the 12- week study period
  • Participant must agree to not use other illicit drugs, including prescription opioid medications, during the 12-week study period
  • Participant must be able to speak, read, and write English
  • Participant must be able to understand the study procedures and agree to participate in the study by providing written informed consent

Who cannot take part

  • Use of pharmacotherapy (i.e., prescription medication or any form of nicotine replacement therapy) to try to quit smoking in the 30 days prior to eligibility screening
  • Use of other tobacco or nicotine products (e.g., cigars, little cigars, electronic cigarettes, nicotine pouches) in the 30 days prior to eligibility screening
  • Use of smoked or vaped cannabis (i.e., marijuana) in the 30 days prior to eligibility screening
  • Use of other illicit drugs, including prescription opioid medications, in the 30 days prior to eligibility screening
  • Pregnant or nursing, or planning to become pregnant or breastfeed in the next three (3) months

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Tobacco use disorder or smoking cessation

Where in United States

  • University of Hawai'iHonolulu, United StatesContact: Pallav Pokhrel, PhD, MPHNot yet recruiting

About the trial

What the trial wants to find out

This study aims to help Native Hawaiian adults quit smoking by testing two common methods: nicotine gum and group-based counseling. Participants will be assigned to one of three groups: (1) nicotine gum only, (2) group counseling only, or (3) a combination of both. The study will take place at public housing sites on O'ahu. Researchers will check if these approaches-alone or in combination-can support people in successfully quitting smoking. The goal is to find out which method works best and is most acceptable in this community.

The 3 groups in the trial

  • NRT Gum OnlyTreatment being tested

    Participants receive nicotine gum (2 mg) according to a 12-week FDA-approved tapering schedule. No counseling is provided.

    Treatment: Nicotine Polacrilex Gum (2 mg)

  • CBGT OnlyTreatment being tested

    Participants attend six weekly sessions of cognitive-behavioral group therapy (CBGT) for smoking cessation. No nicotine gum is provided.

    Treatment: Cognitive Behavioral Group Therapy (CBGT)

  • CBGT + NRT GumTreatment being tested

    Participants receive both nicotine gum (2 mg, tapered over 12 weeks) and attend six weekly CBGT sessions for smoking cessation.

    Treatment: Nicotine Polacrilex Gum (2 mg) and Cognitive Behavioral Group Therapy (CBGT)

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Smoking Cessation Among Native Hawaiians: A Test of Pharmacotherapies and Group-Based Counseling
Criteria questions
Built from NCT07075575, who can take part
Record updated
31 March 2026